Trial Profile
Assessment of the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet Treatment on Blood Pressure When Administered Intermittently for Six Months for the Acute Treatment of Migraine Attacks, With or Without Aura, in Adults.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Sep 2023
Price :
$35
*
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary) ; Naproxen sodium; Sumatriptan
- Indications Migraine
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 01 Dec 2011 Results published in the Journal of Clinical Hypertension (Greenwich).
- 12 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 May 2010 Actual patient number (407) added as reported by ClinicalTrials.gov.